SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-20-000030
Filing Date
2020-07-31
Accepted
2020-07-31 16:18:29
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20200630.htm   iXBRL 10-Q 2525858
2 EX-31.1 a2020q210-qexhibit311.htm EX-31.1 13197
3 EX-31.2 a2020q210-qexhibit312.htm EX-31.2 13195
4 EX-32.1 a2020q210-qexhibit321.htm EX-32.1 10527
10 vrtx-20200630_g1.jpg GRAPHIC 26456
11 vrtx-20200630_g2.jpg GRAPHIC 34885
  Complete submission text file 0000875320-20-000030.txt   10155450

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20200630.xsd EX-101.SCH 42195
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20200630_cal.xml EX-101.CAL 93740
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20200630_def.xml EX-101.DEF 278490
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20200630_lab.xml EX-101.LAB 570492
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20200630_pre.xml EX-101.PRE 400481
12 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20200630_htm.xml XML 2281462
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 201066177
SIC: 2834 Pharmaceutical Preparations